Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track TWST with free AI briefings, catalyst countdowns, and dilution alerts.

TWST · Twist Bioscience Corp

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$166.8M Cash on Hand
60.9mo Cash Runway
Follow TWST by email Get an email when TWST reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about TWST, unsubscribe in one click. Privacy

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

TWST holds $166.8M in cash and short-term investments (as of Jun 30, 2026) and burns about $8.2M/quarter from operations, an estimated runway of 60.9 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 32 · Moderate

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when TWST files for a raise →

👥 Who Owns TWST

Insiders 2% Institutions (522 holders) 98% Public and other holders 0%
HolderTypeShares% of sharesAs of
FMR LLC Institution (13G, 5%+) 9,535,193 13.99% 2026-09-30
T. Rowe Price Associates, Inc. Institution (13G, 5%+) 3,634,470 5.33% 2026-06-30
ARK Investment Management LLC Institution (13G, 5%+) 3,385,850 4.97% 2026-08-31
Vanguard Capital Management Institution (13G, 5%+) 3,101,909 4.55% 2026-03-31
Emily M. Leproust
Chief Executive Officer, Director · +196,240 options
Insider 653,538 0.96% 2026-11-12
Patrick John Finn
President and COO
Insider 233,913 0.34% 2026-11-12
Paula Green
SVP of Human Resources
Insider 126,054 0.18% 2026-11-12
Adam Laponis
Chief Financial Officer
Insider 124,860 0.18% 2026-11-12
Dennis Cho
Officer
Insider 85,665 0.13% 2026-11-12
Robert Chess
Director
Insider 63,612 0.09% 2026-08-07
Robert F. Werner
Chief Accounting Officer
Insider 51,208 0.08% 2026-11-12
Katryn Blake
Director
Insider 17,208 0.03% 2026-08-12

Share count 68,178,692 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full TWST picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for TWST and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.